scholarly article | Q13442814 |
P50 | author | Joana A. Loureiro | Q51836976 |
Maria do Carmo Pereira | Q51836998 | ||
Maria João Ramalho | Q64880671 | ||
P2093 | author name string | Manuel A N Coelho | |
P2860 | cites work | Current Challenges and Opportunities in Treating Glioblastoma. | Q52579808 |
Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment | Q88532378 | ||
Biophysical interaction of temozolomide and its active metabolite with biomembrane models: The relevance of drug-membrane interaction for Glioblastoma Multiforme therapy | Q91223988 | ||
Interaction of natural compounds with biomembrane models: A biophysical approach for the Alzheimer's disease therapy | Q91569726 | ||
Temozolomide resistance in glioblastoma multiforme | Q91792247 | ||
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction | Q38784932 | ||
Temozolomide-loaded PLGA nanoparticles to treat glioblastoma cells: a biophysical and cell culture evaluation | Q38791773 | ||
PLGA nanoparticles as a platform for vitamin D-based cancer therapy | Q38850543 | ||
Nano-structures mediated co-delivery of therapeutic agents for glioblastoma treatment: A review | Q38950420 | ||
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization | Q39629382 | ||
Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles | Q41881058 | ||
A Fractional Factorial Design to Study the Effect of Process Variables on the Preparation of Hyaluronidase Loaded PLGA Nanoparticles | Q42042782 | ||
Polymeric nanoparticles loaded with the 3,5,3'-triiodothyroacetic acid (Triac), a thyroid hormone: factorial design, characterization, and release kinetics. | Q42055713 | ||
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier | Q42153590 | ||
Development and optimization of quercetin-loaded PLGA nanoparticles by experimental design. | Q43245104 | ||
Enhanced sonocatalysis of textile wastewater using bentonite-supported ZnO nanoparticles: Response surface methodological approach. | Q43349072 | ||
Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake | Q44054856 | ||
Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency | Q46675585 | ||
Nanoparticles for multi-modality cancer diagnosis: Simple protocol for self-assembly of gold nanoclusters mediated by gadolinium ions. | Q48881697 | ||
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma | Q24644727 | ||
Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance | Q33578774 | ||
Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: in vitro characterisation | Q33776038 | ||
Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer | Q34479313 | ||
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study | Q36455403 | ||
Principles of nanoparticle design for overcoming biological barriers to drug delivery | Q37162182 | ||
The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells | Q37190466 | ||
Preparation of Temozolomide-Loaded Nanoparticles for Glioblastoma Multiforme Targeting-Ideal Versus Reality | Q37290850 | ||
PLGA-based nanoparticles: an overview of biomedical applications. | Q37986980 | ||
The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles | Q38059207 | ||
Statistical approaches to maximize recombinant protein expression in Escherichia coli: a general review | Q38161273 | ||
Optimization of methazolamide-loaded solid lipid nanoparticles for ophthalmic delivery using Box-Behnken design | Q38194593 | ||
Posttranslational Regulation of O(6)-Methylguanine-DNA Methyltransferase (MGMT) and New Opportunities for Treatment of Brain Cancers. | Q38552355 | ||
Transmission Electron Microscopy as a Tool for the Characterization of Soft Materials: Application and Interpretation. | Q38678664 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P577 | publication date | 2019-08-10 | |
P1433 | published in | Pharmaceutics | Q27723332 |
P1476 | title | Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine | |
P478 | volume | 11 |
Search more.